Megola, Inc. announced the successful completion of its Pilot Scale-up Field Testing with its patent-pending Odor Control (SAPs) for Baby Diapers, Adult Incontinence and Feminine Hygiene Products. The odor control personal hygiene products were provided to a group of incontinent human volunteers in the USA. Skin irritation testing conducted by an independent contractor according to an FDA approved protocol is underway, with results due shortly.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0069 USD | 0.00% | -9.21% | +187.50% |
1st Jan change | Capi. | |
---|---|---|
+187.50% | 2.01M | |
-16.31% | 40.57B | |
+12.64% | 26.04B | |
-5.44% | 16.74B | |
-23.51% | 6.44B | |
+9.20% | 6.16B | |
-1.27% | 3.2B | |
-2.37% | 2.3B | |
-9.92% | 1.97B | |
+25.35% | 955M |
- Stock Market
- Equities
- MGON Stock
- News Megola, Inc.
- Megola, Inc. Completes Pilot Scale-Up Field Testing with its Patent-Pending Odor Control for Baby Diapers, Adult Incontinence and Feminine Hygiene Products